awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36219254-44EF0B19-5813-4B56-AAE2-682E5A157B31
Q36219254-44EF0B19-5813-4B56-AAE2-682E5A157B31
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36219254-44EF0B19-5813-4B56-AAE2-682E5A157B31
Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial.
P2860
Q36219254-44EF0B19-5813-4B56-AAE2-682E5A157B31
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36219254-44EF0B19-5813-4B56-AAE2-682E5A157B31
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
c4964d1bb25070bd95bd307e0b3278ab3c05233e
P2860
Use of anti-VEGF adjuvant therapy in cancer: challenges and rationale